image
Neurocrine Biosciences, Inc. NBIX
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 118.7325
1.04 %
$ 11.8 B
Market Cap
36.09
P/E
BALANCE SHEET
3.72 B ASSETS
14.37%
Growth Rates
1Year 14.37%
3Years 21.52%
5Years 23.28%
7Years 24.16%
10Years 31.36%
1.13 B LIABILITIES
10.75%
Growth Rates
1Year 10.75%
3Years 17.36%
5Years 11.03%
7Years 14.21%
10Years 41.81%
2.59 B EQUITY
16.03%
Growth Rates
1Year 16.03%
3Years 23.52%
5Years 32.38%
7Years 31.94%
10Years 28.64%
BALANCE SHEET DECOMPOSITION
Balance Sheet Neurocrine Biosciences, Inc.
image
Current Assets 1.72 B
Cash & Short-Term Investments 1.08 B
Receivables 479 M
Other Current Assets 170 M
Non-Current Assets 1.99 B
Long-Term Investments 125 M
PP&E 592 M
Other Non-Current Assets 1.28 B
Current Liabilities 508 M
Accounts Payable 110 M
Short-Term Debt 0
Other Current Liabilities 398 M
Non-Current Liabilities 621 M
Long-Term Debt 455 M
Other Non-Current Liabilities 166 M

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996
ASSETS
Cash & Cash Equivalents 233.0 251.1 262.9 340.8 801.0 112.3 141.7 254.7 83.3 74.2 31.0 44.8 63.8 50.1 54.1 37.3 68.5 99.7 81.0 49.9 61.0 105.9 44.3 163.9 21.1 21.3 11.7 15.8 11.3
Short Term Investments 843.1 780.5 726.4 370.5 613.9 558.2 509.2 261.2 224.1 305.0 162.8 101.0 109.3 79.0 72.8 16.1 12.0 79.7 101.6 223.1 240.1 347.3 200.4 156.1 143.6 69.8 0 0 0
Receivables 479.1 439.3 350.0 185.5 157.1 126.6 56.2 31.1 0 0 0 23 K 14.1 1.9 4.5 0 39 K 27 K 7.2 0.9 8.2 0 0 9.9 6.0 1.5 1.4 0.2 1.3
Inventory 57.4 38.3 35.1 30.5 28.0 17.3 10.9 (31.1) 0 0 0 23 K (14.1) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 112.1 97.8 79.1 45.5 30.1 16.6 19.8 7.9 3.1 4.9 4.4 2.7 2.2 1.5 1.7 0.6 0.9 3.5 3.9 5.4 4.5 18.6 3.4 1.6 1.8 2.2 52.5 60.4 59.5
Total Current Assets 1 724.7 1 607.0 1 453.5 972.8 1 016.2 831.0 737.8 554.9 310.4 384.1 198.2 148.5 189.3 132.5 133.1 55.4 81.4 182.9 193.7 279.3 313.8 471.8 248.1 331.5 172.4 94.8 65.6 76.4 72.1
PP&E 592.0 347.3 145.6 155.8 127.4 116.2 33.9 10.8 6.3 3.4 2.5 1.8 1.9 1.6 1.5 2.7 6.2 82.6 91.4 99.3 102.2 56.2 14.1 12.1 11.3 11.2 10.9 8.8 3.5
Intangible Assets 36.5 35.5 37.2 0 0 0 0 0 0 0 0 0 0 18.4 0 23.4 0 0 0 0 0 0 0 0.2 0.4 0.6 1.0 1.2 1.4
Goodwill 0 0 5.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 124.8 849.4 401.5 624.4 265.3 355.6 216.0 247.4 43.5 82.5 37.5 0 0.5 (343.7) 3.7 6.4 21.1 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 755.0 49.6 25.0 4.4 6.4 3.2 5.5 4.5 4.9 4.8 4.8 4.4 4.3 4.3 6.1 (79.0) 9.5 11.1 104.6 104.5 103.2 26.9 4.3 2.6 1.9 2.6 3.0 5.5 1.0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 3 718.7 3 251.4 2 368.7 2 072.5 1 734.7 1 306.0 993.2 817.6 365.1 474.8 243.0 154.7 196.0 138.4 144.4 70.8 118.2 276.7 389.7 483.1 519.2 555.0 266.5 346.4 186.0 109.2 80.5 91.9 78.0
LIABILITIES
Accounts Payable 110.0 108.9 67.3 51.5 39.4 41.4 13.8 5.6 5.1 2.6 0.2 0.1 0.9 1.1 0.8 2.2 1.6 3.8 3.2 3.4 5.4 1.3 2.0 1.5 1.1 2.4 2.5 1.8 0.8
Short Term Debt 0 170.1 169.4 0 0 408.8 0 0 0 0 0 0 0 0 0 4.3 0 1.5 4.5 (0.5) 6.7 4.0 2.7 2.1 1.6 1.0 0.8 0.9 0.8
Other Current Liabilities 397.7 351.4 292.0 194.3 147.1 115.1 74.4 48.0 21.8 19.5 15.4 11.6 11.8 46.0 12.0 7.7 21.6 21.7 12.4 17.9 19.8 55.1 22.2 15.8 12.3 5.2 2.3 4.7 2.5
Total Current Liabilities 507.7 654.8 537.7 245.8 186.5 565.3 88.2 54.4 30.4 25.7 15.7 11.7 15.6 47.1 52.8 20.0 26.1 29.9 20.1 33.7 59.6 110.0 32.5 24.8 15.0 8.6 5.6 7.4 4.1
Long Term Debt 455.1 258.3 93.5 440.4 412.3 86.7 388.5 369.6 0 0 0 0 0 0 0 28.6 0 0 49.2 53.6 59.5 32.5 5.3 3.6 2.3 2.1 2.2 0.7 0.8
Deferred Tax Income 0 0 32.8 0 0 0 (10.2) (10.2) 0 0 0 0 0 0 0 0.5 0 (123.3) 0 0 (2.0) (18.2) (0.8) 0 0 0 0 0 0
Other Liabilities 166.2 106.3 29.7 12.3 9.7 17.1 35.7 21.4 19.8 24.6 18.7 22.6 26.0 4.3 8.1 29.5 10.8 113.5 5.7 5.7 4.4 3.1 3.7 7.6 5.5 2.1 0.7 0.6 0.3
Total Liabilities 1 129.0 1 019.4 660.9 698.5 608.5 669.1 512.4 445.5 50.2 50.3 34.3 34.3 41.6 78.3 125.1 66.9 81.4 158.0 75.0 93.0 125.4 163.8 42.3 36.0 22.8 12.8 8.5 8.7 5.2
EQUITY
Common Stock 100 K 100 K 100 K 100 K 100 K 92 K 91 K 89 K 87 K 86 K 76 K 67 K 66 K 55 K 55 K 44 K 39 K 38 K 38 K 37 K 37 K 35 K 31 K 30 K 25 K 0 0 0 0
Retained Earnings 29.2 (157.1) (406.8) (635.8) (725.4) (1 132.7) (1 177.8) (1 198.9) (1 056.3) (915.2) (826.3) (765.8) (719.7) (724.7) (762.3) (754.3) (703.3) (614.6) (407.4) (300.1) (278.0) (232.2) (201.9) (107.4) (70.5) (41.7) (24.9) (4.9) (10.0)
Other Accumulative Comprehensive Income/Loss 5.8 7.0 (7.9) (1.7) 1.8 1.4 (1.9) (1.9) (0.3) (1.0) (0.3) 5 K 2 K 87 K 48 K 1.2 (1.6) (0.2) 99 K (1.5) (2.3) 0.7 2.1 (2.3) 98 K (0.6) (4.2) (3.0) (2.0)
Total Equity 2 589.7 2 232.0 1 707.8 1 374.0 1 126.2 636.9 480.8 372.1 314.9 424.5 208.7 120.4 154.4 60.1 19.3 4.0 36.8 118.7 314.7 390.1 393.8 391.1 224.3 310.4 163.2 96.4 72.0 83.2 72.8
Total Liabilities and Equity 3 718.7 3 251.4 2 368.7 2 072.5 1 734.7 1 306.0 993.2 817.6 365.1 474.8 243.0 154.7 196.0 138.4 144.4 70.8 118.2 276.7 389.7 483.1 519.2 555.0 266.5 346.4 186.0 109.2 80.5 91.9 78.0
SHARES OUTSTANDING
Common Shares Outstanding 100.4 97.7 95.8 94.6 93.1 91.6 95.4 88.0 86.6 84.5 74.6 66.8 65.6 55.2 52.8 39.1 38.4 38.0 37.7 36.8 36.2 32.4 30.5 26.0 22.1 19.1 18.1 17.0 15.1